DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients
Abroad (travel likely)Recruiting
Conditions
HER2-negative Breast Cancer · Hormone-receptor-positive Breast Cancer · Metastatic Breast Cancer · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · HER2 Negative Breast Carcinoma · Hormone Receptor Positive Breast Carcinoma · Metastatic Breast Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mayo Clinic in Florida, Jacksonville, Florida, United States
Contact: Principal Investigator (Pooja Advani, MBBS, MD)
Study leads
Pooja Advani, MBBS, MD
Principal Investigator
Mayo Clinic